BE0079 InVivoMAb anti-human MHC Class I (HLA-A, HLA-B, HLA-C) 5mg
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0482558
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $652.00
About this award
Bio X Cell has been awarded contract A207_PO-0482558 by the University of Virginia on September 19, 2026, with a total contract value of $652. The prime contractor will deliver one unit of InVivoMAb anti-human Major Histocompatibility Complex Class I (HLA-A, HLA-B, HLA-C) monoclonal antibody product at 5 milligrams concentration to Brandon K. Davidson. The contract is classified under Virginia state procurement.
The deliverable consists of a single line item for a specialized immunological reagent used in research applications. No separate annual value, extended period of performance, or place of performance distinct from the University of Virginia has been specified in the contract award documentation. The unit price for the antibody product is $652 per each.
Line items
| Item | Total |
|---|---|
| BE0079 InVivoMAb anti-human MHC Class I (HLA-A, HLA-B, HLA-C) 5mg | $652.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0482558?
Contract A207_PO-0482558 was awarded to Bio X Cell by University of Virginia on September 19, 2026.
How much is contract A207_PO-0482558 worth?
Its cumulative value is $652.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award